RIPA cell lysis buffer 2, (100 ml)

pyruvate-dehydrogenase inhibitor

Product Name :
RIPA cell lysis buffer 2, (100 ml)

Sequence:

Purity:

Molecular Weight:

Solubility :

Appearance:

Use/Stability :

Description:

CAS :

Solubility:

Formula:

Additional Information :
| Formulation Liquid.58880-19-6 web 50mM TRIS-hydrogen chloride, pH 7.894787-30-5 In Vivo 4, containing 150mM sodium chloride, 1mM EDTA, 1mM EGTA, 1% Triton X-100, 1% sodium deoxycholate and 0.PMID:31335079 1% SDS

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Related Posts

ASTX-029

Product Name : ASTX-029Description:ASTX-029 is an orally bioavailable inhibitor of the extracellular signal-regulated kinases (ERK) 1 and 2, with potential antineoplastic activity. ASTX-029 inhibits ERK-dependent tumor cell proliferation and survival.CAS: 2095719-92-7Molecular Weight:584.04Formula: C29H31ClFN5O5Chemical Name: (R)-2-(6-(5-chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamideSmiles : C[C@H](C(=O)N[C@H](CO)C1C=C(F)C=C(C=1)OC)N1CC2=CC=C(C=C2C1=O)C1=NC(NC2CCOCC2)=NC=C1ClInChiKey: BVRGQPJKSKKGIH-PUAOIOHZSA-NInChi : InChI=1S/C29H31ClFN5O5/c1-16(27(38)34-25(15-37)19-9-20(31)12-22(10-19)40-2)36-14-18-4-3-17(11-23(18)28(36)39)26-24(30)13-32-29(35-26)33-21-5-7-41-8-6-21/h3-4,9-13,16,21,25,37H,5-8,14-15H2,1-2H3,(H,34,38)(H,32,33,35)/t16-,25-/m1/s1Purity: ≥98% (or refer to the Certificate of Analysis)Shipping Condition: Shipped under ambient temperature as non-hazardous […]

Conversely, components of the RNA processing machinery can also affect transcription

uces PD symptoms in RS 1 ApoEnull mice, and that F. nucleatum is able to spread by hematogenous routes and to modulate host immune response and atherosclerotic risk factors, with evidence for both pro- and anti-inflammatory responses and yet does not promote atherosclerotic lesion progression. Previous in vitro studies showed that F. nucleatum is a […]

The hypothesis has been that larger RGCs were selectively lost in the early stage of glaucoma

ls Feedback loops to strengthen the metabolic reprogramming Although over-active PDH can promote reactive oxygen species production during high mitochondrial flux, dysfunction of PDH within the mitochondrion is invariably associated with increased production of ROS. Thus, Pvract cells exhibit high ROS levels detected by direct staining with the DHE dye or as monitored by gstD-GFP […]